ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AstraZeneca signs deal to sell commercial rights for Seloken in Europe
pharmaceutical-technology
May 27, 2017AstraZeneca has entered an agreement to provide the commercial rights for Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treatments in Eur -
AstraZeneca enters agreement with Recordati for Seloken in Europe
europeanpharmaceuticalreview
May 25, 2017AstraZeneca has entered into an agreement with Recordati for the commercial rights to Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and associated Logimax fixed-dose combination (metoprolol succinate and felodipine) treat
Pharma Sources Insight January 2025
